Thrombin-activatable fibrinolysis inhibitor in human abdominal aortic aneurysm disease

K. I. Bridge, L. Bollen, J. Zhong, M. Hesketh, F. L. Macrae, A. Johnson, H. Philippou, D. J. Scott, A. Gils, R. A. S. Ariёns
  • Journal of Thrombosis and Haemostasis, September 2017, Wiley
  • DOI: 10.1111/jth.13804

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Helen Philippou

In partnership with: